New York Life Investment Management’s New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF LRND Stock Holding History

New York Life Investment Management’s Portfolio LRND Stock Details LRND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$379M	Buy	8,599,898 +3,180,497	+59%	+$136M	2.65%	4
2026 Q1	$201M	Buy	5,419,401 +3,814,585	+238%	+$151M	1.7%	10
2025 Q4	$65.4M	Buy	1,604,816 +1,414,816	+745%	+$57.3M	0.56%	32
2025 Q3	$7.56M	Hold	190,000	–	–	0.07%	254
2025 Q2	$6.86M	Hold	190,000	–	–	0.06%	258
2025 Q1	$6.11M	Hold	190,000	–	–	0.06%	278
2024 Q4	$6.49M	Hold	190,000	–	–	0.06%	264
2024 Q3	$6.33M	Hold	190,000	–	–	0.06%	283
2024 Q2	$6.22M	Hold	190,000	–	–	0.06%	273
2024 Q1	$5.98M	Hold	190,000	–	–	0.06%	289
2023 Q4	$5.38M	Hold	190,000	–	–	0.06%	306
2023 Q3	$4.77M	Hold	190,000	–	–	0.05%	315
2023 Q2	$4.89M	Hold	190,000	–	–	0.05%	315
2023 Q1	$4.36M	Hold	190,000	–	–	0.05%	343
2022 Q4	$3.79M	Hold	190,000	–	–	0.04%	383
2022 Q3	$3.65M	Hold	190,000	–	–	0.04%	371
2022 Q2	$190K	Hold	190,000	–	–	﹤0.01%	1233
2022 Q1	$4.78M	Buy	+190,000	New	+$4.63M	0.25%	29

Other funds holding LRND

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sankala Group Lyons, Colorado $150M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

New York Life Investment Management's LRND Position: Q2 2026 in Review

New York Life Investment Management increased its New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) stake by 59% in Q2 2026, buying an estimated $136M and bringing the position to 8,599,898 shares worth $379M. The position accounts for 2.65% of the portfolio, ranked #4.

New York Life Investment Management first reported a position in LRND in Q1 2022 and has held it in 18 quarters since. 6 funds tracked by Wall St. Rank hold LRND as of Q2 2026.

New York Life Investment Management held 8,599,898 shares of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF worth $379M as of Q2 2026.
New York Life Investment Management bought 3,180,497 New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF shares in Q2 2026, an estimated $136M.
New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF made up 2.65% of New York Life Investment Management's portfolio in Q2 2026, its #4 holding.
New York Life Investment Management first reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in Q1 2022 and has held it in 18 quarters since.
6 funds tracked by Wall St. Rank held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.